.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Julphar
Fuji
Johnson and Johnson
Boehringer Ingelheim
Chinese Patent Office
Dow
Teva
Colorcon

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,236,345

« Back to Dashboard

Which drugs does patent 8,236,345 protect, and when does it expire?


Patent 8,236,345 protects AVANDAMET and is included in one NDA. There has been one Paragraph IV challenge on Avandamet.

This patent has sixty-four patent family members in forty-four countries.

Summary for Patent: 8,236,345

Title:Composition and use
Abstract: A pharmaceutical composition, comprising a thiazolidinedione, such as Compound (I), metformin hydrochloride and a pharmaceutically acceptable carrier, wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier in the pharmaceutical composition and the use of such a composition in medicine.
Inventor(s): Lewis; Karen (Verona, IT), Lilliott; Nicola Jayne (London, GB), MacKenzie; Donald Colin (Harlow, GB)
Assignee: SmithKline Beecham Limited (Brentford, Middlesex, GB)
Application Number:11/779,546
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Sb PharmcoAVANDAMETmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL021410-004Aug 25, 2003DISCNYesNo► Subscribe► Subscribe► SubscribeY
Sb PharmcoAVANDAMETmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL021410-005Aug 25, 2003DISCNYesNo► Subscribe► Subscribe► SubscribeY
Sb PharmcoAVANDAMETmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL021410-001Oct 10, 2002DISCNYesNo► Subscribe► Subscribe► SubscribeY
Sb PharmcoAVANDAMETmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL021410-002Oct 10, 2002DISCNYesNo► Subscribe► Subscribe► SubscribeY
Sb PharmcoAVANDAMETmetformin hydrochloride; rosiglitazone maleateTABLET;ORAL021410-003Oct 10, 2002DISCNYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,236,345

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9927119.9Nov 16, 1999
United Kingdom9927120.7Nov 16, 1999
United Kingdom0013236.5May 31, 2000
United Kingdom0013240.7May 31, 2000

International Patent Family for Patent: 8,236,345

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Uruguay26439► Subscribe
Ukraine73150► Subscribe
TaiwanI240626► Subscribe
Slovakia6792002► Subscribe
Slovakia286985► Subscribe
Slovenia1231918► Subscribe
Serbia51343► Subscribe
Yugoslavia38802► Subscribe
Poland200943► Subscribe
Portugal1231918► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Argus Health
McKesson
Daiichi Sankyo
Johnson and Johnson
Farmers Insurance
Harvard Business School
Boehringer Ingelheim
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot